484
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

Not all CALR mutations are created equal

, , , , , & show all
Pages 2482-2483 | Received 12 May 2015, Accepted 11 Jun 2015, Published online: 21 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Olivier Mansier, Marina Migeon, Gabriel Etienne, Audrey Bidet & Eric Lippert. (2016) JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens. Leukemia & Lymphoma 57:8, pages 1949-1951.
Read now

Articles from other publishers (3)

Hany Sakr, Kelli Clark Schneider, Gurunathan Murugesan, Juraj Bodo, Eric D. Hsi & James R. Cook. (2018) pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms. Applied Immunohistochemistry & Molecular Morphology 26:2, pages 147-152.
Crossref
Laila Nomani, Juraj Bodo, Xiaoxian Zhao, Lisa Durkin, Sanam Loghavi & Eric D. Hsi. (2016) CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms . American Journal of Clinical Pathology 146:4, pages 431-438.
Crossref
G. Murugesan, J. Guenther‐Johnson, F. Mularo, J. R. Cook & T. M. Daly. (2016) Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR . International Journal of Laboratory Hematology 38:3, pages 284-297.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.